Chondrolysis is defined as the rapid and diffuse loss of articular cartilage, typically within 12 months after surgery. Although described in nearly all diarthroidial joints, recent studies have shown that chondrolysis has been misdiagnosed in numerous case reports. This study aimed to determine contributing factors associated with the misdiagnosis of chondrolysis to help improve accurate diagnostication and clinical decision making. METHODS: A systematic literature review identified 128 publications on 783 joints (626 hips, 128 shoulders, and 29 knees) diagnosed as chondrolysis. Among these, 72 joints (48% knees, 9% shoulders, and 7% hips) were determined to be misdiagnosed by consensus across five orthopaedic surgeons. A broad range of data was examined in relation to misdiagnosis. For all cases, the presenting diagnosis and surgical procedure(s) as well as other potential contributors including chemical, thermal, and mechanical factors were examined to estimate the differential risk of rapidly developing osteoarthritis which was categorized as low, moderate, or high. Descriptive statistics, bivariate comparisons, and multivariate regression analyses were performed, with pϽ0.05 denoting significance. RESULTS: Misdiagnosis of chondrolysis was neither associated with arthroscopic procedures nor chemical, thermal, or mechanical factors during surgery. Among correctly diagnosed cases, the risk of developing rapid osteoarthritis was considered low among 94.4% (671/711), moderate among 1.0% (7/711), and high among 4.6% (33/711). In contrast, among misdiagnosed cases, 13.9% (10/72) of presenting diagnoses were considered low risk for osteoarthritis, 19.4% (14/72) moderate, and 66.7% (48/72) high. After adjusting for potential confounders, the single most significant predictor associated with misdiagnosis of chondrolysis was a presenting medical condition that increased the risk of developing rapid osteoarthritis (pϽ0.01). CONCLUSIONS: Misdiagnosis of chondrolysis appears to be strongly correlated with the risk of rapidly developing osteoarthritis, a pathology that is characterized by chronic and focal degeneration of cartilage rather than rapid and diffuse cartilage loss that signify chondrolysis. 
OBJECTIVES:
Correction of astigmatism during cataract surgery is important to free the patient from distance vision spectacles. Several techniques are available: Laser, Toric intraocular lenses and LRI. This abstract reports on the long term effectiveness of LRI. METHODS: The charts of all patients having had LRI during cataract surgery done by LG were extracted. The LRI consisted of a 6 mm length contralateral limbal incision with a 600m depth calibrated lancet. The main outcome was objective keratometry. Vector analysis was conducted according to Alpins and Goggin. Success was defined as at least one diopter cylinder reduction in its axis (ϩ/Ϫ 22.5°), independent of the pre-operative astigmatism (emmetropia was not the objective). Keratometries performed before 3 months were not taken into account in the survival analyses (Kaplan-Meyer). RESULTS: A total of 129 eyes were included in the analysis. Patients mean age was 68.3 and the sex ratio was 47 males: 53 females. Average follow-up was 2.0 years. On average, the cylinder was 1.8D (1.1) before surgery and 1.4D (0.9) at one year. No major axis shift was observed on average (from -1.6°at week 4 to 2.9°after 2 years) while its standard deviation was high (from 73°at week 4 to 62°after 2 years). Success rates were 78% at week 50, 48% at week 100 and 23% at week 250. CONCLUSIONS: A 6 mm length contra-lateral limbal incision does not allow a 1D cylinder correction. The predictability of correcting astigmatism along the cylinder axis is low. Consequently, the success rate is low at week 50 and declining over the long term. The probability to be free of distance vision glasses and to realize the associated savings is uncertain with LRI. Lastly, interpreting effectiveness results of LRI based on vector analysis parameter averages is misleading. Charité, Berlin, Germany OBJECTIVES: Evaluation of diagnostic, epidemiological, microbiological, surgical, and economic parameters of periprosthetic hip and knee infections. METHODS: Data of a large Berlin hospital group (Ͼ5000 beds) were analysed over 3 years for the above mentioned criteria. RESULTS: A total of 7524 arthroplasties from January 1, 2007 -December 2009 were performed because of femoral neck fractures and arthritis of hip/knee; 18.1% of them were revisions, 319 of these (259 patients) due to infection. All received major revision surgery; i.e. 208 patients underwent 1 revision, 43 patients 2, 7 patients 3, and 1 patient 4. Pathogen organisms were 57 x coag-neg. Staphylococci, 54 x Staph. aureus, 21 x Enterococci, and 19 x Streptococci, with a wide variety of further bacteria in fewer numbers. 72 SSI-infections were multibacterial. MRSA was encountered 8 x. In 99 specimen bacteriology was negative. Most revisions were performed as two-stage procedures. Pre-op joint puncture was carried out 92 x, with a positive result in 59 cases. Antibiotic treatment was more effective, when pre-op bacterial diagnosis permitted a targeted drug application. Age and ASA classification played no role in the prevalence of periprosthetic infections. There were differences between hospitals, septic surgery ranging from 4.5% up to 40.9% of all operative revisions (specialized departments). Length and frequency of hospital stay were extended grossly, when infection occurred, as well as the number of diagnostic and therapeutic measures. Besides the individual disaster this resulted in a large increase in total cost for septic revision surgery. CONCLUSIONS: Periprosthetic infections represent a catastrophe for the patient, a burden for the therapeutic team and an economical hazard for society. Methods to avoid this complication are high hygienic standards, early clinical detection of infection, meticulous, repeated bacterial diagnostics, radical surgery, and specific antibiotic treatment. The present study confirms these recommendations by analysis of Ͼ300 surgical revisions of alloarthroplastic infections. , other marketed phakic intraocular lenses (PIOLs) in Europe, and laser refractive surgery (RS) in patients with high myopia (HM). METHODS: MEDLINE, Embase, and Cochrane databases were searched for randomised controlled trials and observational studies conducted in HM patients. Two reviewers undertook data extraction followed by reconciliation of included studies. Meta-analysis was performed to combine comparative data; weighted means were calculated for single arm studies. The quality of single arm studies was assessed using Downs and Black checklist (score Ն12: excellent quality OBJECTIVES: Surgical procedures may potentially interfere with anticancer drug therapy for metastatic colorectal cancer (mCRC). The objective of this study was to examine the proportion of patients with mCRC who underwent major surgeries.
PSU7 IMPLICATIONS OF ALLOARTHROPLASTIC INFECTIONS IN HIP AND KNEE SURGERY

PSU8 RISKS AND BENEFITS OF ACRYSOF
METHODS:
Using a large US medical claims database from a nationally commercially-insured population, patients with diagnosed mCRC between January 2004 and March 2010 were identified. The first metastasis diagnosis date served as the index date. Patients were followed from the index date to death, disenrollment, or end of the study period, whichever occurred first. Major surgery was defined according to the list of major surgeries developed by the National Committee for Quality Assurance using Current Procedural Terminology procedure codes. Major surgeries were examined by anatomic locations: 1) colon or rectum; 2) liver or lung; and 3) all other anatomic sites. Major surgeries on colon or rectum were assessed separately, since they likely include a high percentage of interventions to remove primary tumors. The proportion of major surgeries was descriptively analyzed.
RESULTS:
The study sample included 4768 mCRC patients who met the study inclusion and exclusion criteria between January 2004 and March 2010. Mean age was 60.0 years old and 45.9% of patients were female. Mean length of follow-up observation period was over one year (414 days). Overall, 42.3% of patients had at least one major surgery on anatomic sites other than colon/rectum after mCRC diagnosis. By anatomic locations, 17.6% of patients had major surgeries on liver or lung (13.4% on liver and 4.9% on lung); and 32.3% had major surgeries on all other anatomic sites. Major surgeries on colon or rectum occurred in 35.9% of patients (32.9% on colon and 4.1% on rectum). CONCLUSIONS: Major surgeries are highly prevalent in patients with mCRC from this commercially insured population after mCRC diagnosis. This might have implications for anticancer drug therapy in mCRC patients. 
Surgery -Cost Studies
PSU10 ECONOMIC EVALUATION OF MAGNETIC RESONANCE GUIDED FOCUSED ULTRASOUND IN PATIENTS WITH UTERINE FIBROIDS IN GERMANY
OBJECTIVES:
Costs related to Magnetic Resonance Guided Focused Ultrasound (MR-HIFU) for uterine fibroids have not been compared to alternative treatments being performed in Germany up to now. Hence, the purpose of this analysis was to identify the cost-consequences of hysterectomy, myomectomy, uterine artery embolization (UAE) and MR-HIFU in the first year of therapy. In addtition the budget impact of the MR-HIFU from the perspective of the NHS (direct costs) and social perspective (indirect costs) should be analysed. METHODS: The cost of leiomyoma-related hospitalization and patient follow-up was calculated based on data from statistics of the Hospital Remuneration System, the G-DRG hospital payment scheme and the office-based doctors' fee scale. The cost caused due to recovery and disability was estimated based on information from the Federal Statistical Office and data of the Federal Health Reporting. Experts were interviewed to provide follow-up resource use information. RESULTS: A total of 78,229 hospitalized leiomyoma-related cases were treated in year 2009. 80% were hysterectomies, 14% myomectomies and 6% were related to other therapies. Concerning the therapy cost per patient, hysterectomy reveals the highest therapy cost, (€5913) followed by myomectomy (€5793), UAE (€4675) and MR-HIFU (€4311). In a scenario without MR-HIFU the cost per case accrued to a total of €5840. The budget impact analyse targeting a patient group between 30 and 45 years of age, reveals a potential costbenefit of €1529 per patient if MR-HIFU would be introduced in the SHI system. CONCLUSIONS: Our results suggest that MR-HIFU due to the administration in the outpatient sector, the low complication rate and the low disability cost should be considered as a cost-favourable alternative for the therapy of uterine fibroids. 
PSU11 MEDICO-ECONOMIC ANALYSIS OF THE IMPACT OF MALNUTRITION ON THE POST-OPERATIVE COURSE OF COLORECTAL CANCER PATIENTS
OBJECTIVES:
The aim of this study was to assess the clinical and economic impact of malnutrition in post-surgery colorectal cancer patients. METHODS: We performed post-hoc analyses of the data collected in the Alves and al* prospective study. The following criteria for malnutrition were used: weight loss Ͼ10% in the 6 months pre-surgery and/or BMIϽ18.5 (pts Ͻ70 years) or Ͻ21 (pts Ն70 years). 2 groups (gps) were created a posteriori: Well-Nourished (WN) and Malnourished (MN) pts. Postoperative morbidity, mortality, hospital length-of-stay (LOS), and hospital discharge setting were compared between the 2 gps. Individual costs were valued using the French National Cost Study. We defined 3 scenarios: the most accurate estimate and the upper and lower possible limits of this estimate. The economic impact of malnutrition was assessed by calculating the difference in cost per hospital stay between MN and WN pts. RESULTS: A total of 762 pts were included in the analyses. Gps had the same characteristics, except more MN pts underwent emergent surgery. Complication rate was not significantly different between the 2 gps; mortality was higher in MN pts (7.4% vs. 4.1%, pϭ0.056) and MN pts had a mean LOS 3.1 days longer than WN pts (pϭ0.004). A greater proportion of MN pts could not be discharged and were referred to another facility (69.6% vs. 54.2%, pϭ0.027). Malnutrition impacts the cost per hospital stay by about 3154€ per patient (most accurate estimate), creating an annual impact of 9,572,770€ for French public hospitals. CONCLUSIONS: Malnutrition in colorectal cancer surgical pts is associated with a significant increase of LOS and delays returning home following hospitalization; both have significant budget impact. Prospective studies are needed to further investigate this impact and related cost-benefit of (specialized) nutritional support in this homogeneous category of patients. 
PSU12 ESTIMATING COST AND RESOURCE USE FOR WHOLE BRAIN RADIATION VERSUS STEREOTACTIC RADIOSURGERY TREATMENTS AMONG BRAIN METASTASIS PATIENTS
OBJECTIVES:
To examine real world health care utilization (HCU) and costs associated with whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) as the initial or only treatment of brain metastasis (BrMets). METHODS: A retrospective longitudinal analysis utilized claims data from a national health insurer, identifying patients Ն18 yrs with Ն2 claims Ն7 days apart for BrMets (ICD-9 198.3x) from 1/2004-4/2010. The index date was first BrMts claim date. Pre-index period of Ն6 months and Ն1 month post-index enrollment (Ͻ1 month was permitted if due to death). Patients with primary brain cancers were excluded. HCU and all-cause per-patient per-month (PPPM) costs were examined. RESULTS: The study included 1,901 and 303 patients who received WBRT or SRS as first or only treatment, with 179d vs. 306d follow-up, respectively. Baseline Charlson comorbidity scores were similar. Mean age at BrMets diagnosis was higher for WBRT (59yrs) vs. SRS (57yr) [p-valueϭ0.002 ]. Rates of HCU (events/person-month) were higher among WBRT vs. SRS patients for office visits (5.29 vs. 3.69), ER visits (0.25 vs. 0.17), and inpatient stays (0.26 vs. 0.17); rates of outpatient visits were lower among WBRT patients (2.31 vs. 3.24) [p-valueϽ0.001] . Total costs PPPM were higher for the SRS ($20,682) vs. WBRT cohort ($16,909) [p-valueϭ0.005 ]. Outpatient costs PPPM was the major costdriver among the SRS cohort ($8,936, 43% of total) vs. $3,192 (19% of total) for WBRT. Office costs PPPM contributed most to overall cost among WBRT ($3,428, 20% of total) vs. $3,053 (18% of total) for SRS. Pharmacy costs PPPM were higher for the SRS ($1,232) vs. WBRT cohort ($692) [p-value Ͻ0.001] . CONCLUSIONS: BrMets patients with SRS incurred higher cost compared to WBRT patients. SRS is recommended for BrMets patients with Յ3 lesions and WBRT in Ͼ3 lesions may explain longer survival among SRS patients. Additional studies are augmented to understand differences.
